Can This Gepant be an Effective Preventive Treatment Option for Tough to Treat Episodic Migraine?

Migraine Minute News Update

English - May 31, 2024 14:43 - 44 seconds - 1.02 MB - ★★★★★ - 3 ratings
Health & Fitness News headache health medical medicine migraine research wellness Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Comparing Anti-CGRP monoclonal antibodies to OnabotulinumtoxinA for chronic migraine

Next Episode: Do CGRP Monoclonal Antibodies wear off at the end of the month?

A study in the Lancet found one oral gepant to be safe and effective in people with episodic migraine who have failed two to four classes of preventive treatments. Molly O’Brien explains in this Migraine Minute News Update. Read the study here: https://bit.ly/3w3ZM45